ArticlePloS one2025

Retraction: Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by Norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.